OncoCyte Corp
NASDAQ:OCX

Watchlist Manager
OncoCyte Corp Logo
OncoCyte Corp
NASDAQ:OCX
Watchlist
Price: 3.44 USD 12.05% Market Closed
Market Cap: 98.4m USD

Wall Street
Price Targets

OCX Price Targets Summary
OncoCyte Corp

Wall Street analysts forecast OCX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OCX is 4.59 USD with a low forecast of 4.04 USD and a high forecast of 5.25 USD.

Lowest
Price Target
4.04 USD
17% Upside
Average
Price Target
4.59 USD
33% Upside
Highest
Price Target
5.25 USD
53% Upside
OncoCyte Corp Competitors:
Price Targets
BCAX
Bicara Therapeutics Inc
116% Upside
BCYC
Bicycle Therapeutics PLC
235% Upside
PYC
PYC Therapeutics Ltd
190% Upside
MDXG
MiMedx Group Inc
82% Upside
GLPG
Galapagos NV
19% Upside
SNDX
Syndax Pharmaceuticals Inc
229% Upside
STOK
Stoke Therapeutics Inc
156% Upside
BSLN
Basilea Pharmaceutica AG
102% Upside

Revenue
Forecast

Revenue Estimate
OncoCyte Corp

The compound annual growth rate of OncoCyte Corp's revenue for the next 3 years is 92%.

N/A
Past Growth
92%
Estimated Growth
Estimates Accuracy
-20%
Average Miss

Operating Income
Forecast

Operating Income Estimate
OncoCyte Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

Net Income Estimate
OncoCyte Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-89%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OCX's stock price target?
Price Target
4.59 USD

According to Wall Street analysts, the average 1-year price target for OCX is 4.59 USD with a low forecast of 4.04 USD and a high forecast of 5.25 USD.

What is OncoCyte Corp's Revenue forecast?
Projected CAGR
92%

The compound annual growth rate of OncoCyte Corp's revenue for the next 3 years is 92%.

Back to Top